144 related articles for article (PubMed ID: 8394297)
21. Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Jabboury K; Frye D; Holmes FA; Fraschini G; Hortobagyi G
Invest New Drugs; 1989 Jul; 7(2-3):225-9. PubMed ID: 2793377
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
23. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
[TBL] [Abstract][Full Text] [Related]
24. 4'-EPI-doxorubicin in advanced lung cancer. A phase II trial.
Giaccone G; Donadio M; Bonardi G; Iberti V; Calciati A
Invest New Drugs; 1990 Nov; 8(4):393-6. PubMed ID: 1964677
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma.
Chitambar CR; Zahir SA; Ritch PS; Anderson T
Am J Clin Oncol; 1997 Apr; 20(2):173-8. PubMed ID: 9124195
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of gallium nitrate in patients with advanced malignant melanoma.
Casper ES; Stanton GF; Sordillo PP; Parente R; Michaelson RA; Vinceguerra V
Cancer Treat Rep; 1985 Sep; 69(9):1019-20. PubMed ID: 4028034
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer.
Canfield VA; Lyss AP
Invest New Drugs; 1993 Nov; 11(4):335-6. PubMed ID: 8157476
[No Abstract] [Full Text] [Related]
28. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Warrell RP; Murphy WK; Schulman P; O'Dwyer PJ; Heller G
J Clin Oncol; 1991 Aug; 9(8):1467-75. PubMed ID: 1906532
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of CI-980 in previously untreated extensive small cell lung cancer: an Ohio State University phase II research consortium study.
Thomas JP; Moore T; Kraut EH; Balcerzak SP; Galloway S; Vandre DD;
Cancer Invest; 2002; 20(2):192-8. PubMed ID: 11901539
[TBL] [Abstract][Full Text] [Related]
30. Gallium nitrate revisited.
Chitambar CR
Semin Oncol; 2003 Apr; 30(2 Suppl 5):1-4. PubMed ID: 12776253
[TBL] [Abstract][Full Text] [Related]
31. Phase I-II trial of gallium nitrate for advanced hypernephroma.
Schwartz S; Yagoda A
Anticancer Res; 1984; 4(4-5):317-8. PubMed ID: 6486736
[TBL] [Abstract][Full Text] [Related]
32. Gallium nitrate in the treatment of lymphoma.
Straus DJ
Semin Oncol; 2003 Apr; 30(2 Suppl 5):25-33. PubMed ID: 12776257
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of carbetimer in non-small cell lung cancer.
Keaton M; Brown T; Craig J; Fries G; Harmon G; Zaloznik A; Orczyk G; Von Hoff D
Invest New Drugs; 1990 Nov; 8(4):385-6. PubMed ID: 1964676
[No Abstract] [Full Text] [Related]
34. New perspectives in lung cancer.5. New drugs in lung cancer.
Talbot DC; Smith IE
Thorax; 1992 Mar; 47(3):188-94. PubMed ID: 1325676
[No Abstract] [Full Text] [Related]
35. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses.
Collery P; Morel M; Desoize B; Millart H; Perdu D; Prevost A; Vallerand H; Pechery C; Choisy H; Etienne JC
Anticancer Res; 1991; 11(4):1529-32. PubMed ID: 1660690
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.
Georgiadis MS; Schuler BS; Brown JE; Kieffer LV; Steinberg SM; Wilson WH; Takimoto CH; Kelley MJ; Johnson BE
J Clin Oncol; 1997 Feb; 15(2):735-43. PubMed ID: 9053499
[TBL] [Abstract][Full Text] [Related]
37. Gallium compounds as antineoplastic agents.
Chitambar CR
Curr Opin Oncol; 2004 Nov; 16(6):547-52. PubMed ID: 15627016
[TBL] [Abstract][Full Text] [Related]
38. Gallium nitrate for the treatment of non-Hodgkin's lymphoma.
Chitambar CR
Expert Opin Investig Drugs; 2004 May; 13(5):531-41. PubMed ID: 15155128
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.
Ettinger DS
J Clin Oncol; 1990 Mar; 8(3):374-7. PubMed ID: 2155306
[No Abstract] [Full Text] [Related]
40. Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.
Salazar R; Cortés-Funes H; Casado E; Pardo B; López-Martín A; Cuadra C; Tabernero J; Coronado C; García M; Soto Matos-Pita A; Miguel-Lillo B; Cullell-Young M; Iglesias Dios JL; Paz-Ares L
Cancer Chemother Pharmacol; 2013 Jul; 72(1):75-83. PubMed ID: 23645288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
